Insider Transactions in Q4 2024 at Silverback Therapeutics, Inc. (SBTX)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 16
2024
|
Kathleen D. Scott Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
12,500
-71.64%
|
$200,000
$16.0 P/Share
|
|
Oct 16
2024
|
Kathleen D. Scott Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+41.74%
|
$12,500
$1.5 P/Share
|
|
Oct 15
2024
|
Richard E Lowenthal PRESIDENT AND CEO |
SELL
Open market or private sale
|
Indirect |
100,000
-2.39%
|
$1,400,000
$15.0 P/Share
|
|
Oct 15
2024
|
Sarina Tanimoto CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Indirect |
100,000
-2.39%
|
$1,400,000
$15.0 P/Share
|
|
Oct 08
2024
|
Richard E Lowenthal PRESIDENT AND CEO |
SELL
Open market or private sale
|
Indirect |
100,000
-3.58%
|
$1,300,000
$13.83 P/Share
|
|
Oct 08
2024
|
Sarina Tanimoto CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Indirect |
100,000
-3.58%
|
$1,300,000
$13.83 P/Share
|